446 related articles for article (PubMed ID: 20170672)
1. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
Berrendero F; Robledo P; Trigo JM; Martín-García E; Maldonado R
Neurosci Biobehav Rev; 2010 Nov; 35(2):220-31. PubMed ID: 20170672
[TBL] [Abstract][Full Text] [Related]
2. [Development of physical dependence on nicotine and endogenous opioid system--participation of α7 nicotinic acetylcholine receptor].
Kishioka S; Kiguchi N; Kobayashi Y; Saika F; Yamamoto C
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Oct; 49(5):227-37. PubMed ID: 25651617
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioid system: a promising target for future smoking cessation medications.
Norman H; D'Souza MS
Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
Maldonado R; Berrendero F
Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
[TBL] [Abstract][Full Text] [Related]
5. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
[TBL] [Abstract][Full Text] [Related]
6. Nicotine and endogenous opioids: neurochemical and pharmacological evidence.
Hadjiconstantinou M; Neff NH
Neuropharmacology; 2011 Jun; 60(7-8):1209-20. PubMed ID: 21108953
[TBL] [Abstract][Full Text] [Related]
7. Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway.
Carboni L; Romoli B; Romualdi P; Zoli M
Drug Alcohol Depend; 2016 Sep; 166():150-8. PubMed ID: 27430399
[TBL] [Abstract][Full Text] [Related]
8. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
D'Souza MS; Markou A
Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417
[TBL] [Abstract][Full Text] [Related]
9. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.
Berrendero F; Mendizábal V; Robledo P; Galeote L; Bilkei-Gorzo A; Zimmer A; Maldonado R
J Neurosci; 2005 Feb; 25(5):1103-12. PubMed ID: 15689546
[TBL] [Abstract][Full Text] [Related]
10. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
D'Souza MS
Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
[TBL] [Abstract][Full Text] [Related]
11. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
[TBL] [Abstract][Full Text] [Related]
12. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.
Li X; Semenova S; D'Souza MS; Stoker AK; Markou A
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):554-65. PubMed ID: 23752091
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.
Scherma M; Muntoni AL; Melis M; Fattore L; Fadda P; Fratta W; Pistis M
Psychopharmacology (Berl); 2016 May; 233(10):1765-77. PubMed ID: 26728894
[TBL] [Abstract][Full Text] [Related]
14. Nicotine addiction.
Benowitz NL
Prim Care; 1999 Sep; 26(3):611-31. PubMed ID: 10436290
[TBL] [Abstract][Full Text] [Related]
15. Nicotine effects and the endogenous opioid system.
Kishioka S; Kiguchi N; Kobayashi Y; Saika F
J Pharmacol Sci; 2014; 125(2):117-24. PubMed ID: 24882143
[TBL] [Abstract][Full Text] [Related]
16. The endogenous opioid system: a common substrate in drug addiction.
Trigo JM; Martin-García E; Berrendero F; Robledo P; Maldonado R
Drug Alcohol Depend; 2010 May; 108(3):183-94. PubMed ID: 19945803
[TBL] [Abstract][Full Text] [Related]
17. [The endogenous opioid system and drug addiction].
Maldonado R
Ann Pharm Fr; 2010 Jan; 68(1):3-11. PubMed ID: 20176158
[TBL] [Abstract][Full Text] [Related]
18. Synaptic plasticity and nicotine addiction.
Dani JA; Ji D; Zhou FM
Neuron; 2001 Aug; 31(3):349-52. PubMed ID: 11516393
[TBL] [Abstract][Full Text] [Related]
19. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Smith LC; George O
Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
[TBL] [Abstract][Full Text] [Related]
20. [Nicotine dependence].
Kawazoe S; Shinkai T
Nihon Rinsho; 2015 Sep; 73(9):1516-21. PubMed ID: 26394514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
